1-3 of 3
enterococcal bacteremia
Close
Sort by
Journal Articles

Post-Transplant Cyclophosphamide in Allogeneic Bone Marrow Transplantation for the Treatment of Benign Hematologic Diseases

Mark Leick, MD, Bradley Hunter, MD MPH, Zachariah Defilipp, MD, Bimalangshu Dey, MD, Areej El-Jawahri, MD, Matthew J. Frigault, MD, Steven L McAfee, MD, Thomas Spitzer, MD, Paul V. O'Donnell, MD PhD, Yi-Bin Chen
Journal: Blood
Blood (2019) 134 (Supplement_1): 1978.
https://doi.org/10.1182/blood-2019-128295
Published: 2019
Journal Articles

Intestinal Microbiota Injury during Allo-Hsct Is Generalizable across Transplantation Centers and Is Associated with Increased Mortality, Broad-Spectrum Antibiotics, and Decreased Calorie Intake

Jonathan U. Peled, MD, Antonio Gomes, PhD, Marissa L. Buchan, MS, Christoph K. Stein-Thoeringer, MD, John B. Slingerland, BS, Ann E. Slingerland, BS, Daniela Weber, MSc, Anthony D. Sung, MD, Molly Maloy, MS, Tatanisha Peets, MPH, RD, Sergio A. Giralt, MD, Robert R. Jenq, MD, Ying Taur, MD MPH, Xavier B. Joao, PhD, Eric G. Pamer, MD, Nelson J. Chao, MDM.B.A, Ernst Holler, MD, Marcel R.M. van den Brink, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 750.
https://doi.org/10.1182/blood.V130.Suppl_1.750.750
Published: 2017
Journal Articles

Phase I Study Of LY2784544, a JAK2 Selective Inhibitor, In Patients With Myelofibrosis (MF), Polycythemia Vera (PV), and Essential Thrombocythemia (ET)

Srdan Verstovsek, MD, PhD, Ruben A Mesa, MD, Mohamed E Salama, MD, Jennifer L K Giles, BSc, Celine Pitou, PharmD, Annamaria Hayden Zimmermann, MS, Gregory L Price, MPH, Richard A Walgreen, MD, Josef Prchal, MD
Journal: Blood
Blood (2013) 122 (21): 665.
https://doi.org/10.1182/blood.V122.21.665.665
Published: 2013